Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
作者信息
Werbel William A, Boyarsky Brian J, Ou Michael T, Massie Allan B, Tobian Aaron A R, Garonzik-Wang Jacqueline M, Segev Dorry L
机构信息
Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
Abstract
摘要
相似文献
1
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
2
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
3
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
4
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
5
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
6
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
7
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
8
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
9
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration.
Transplantation. 2021 Jul 1;105(7):e72-e73. doi: 10.1097/TP.0000000000003764.
10
Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients.
J Infect Dis. 2024 Sep 23;230(3):e591-e600. doi: 10.1093/infdis/jiae140.
引用本文的文献
1
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients.
NPJ Vaccines. 2025 Jul 1;10(1):140. doi: 10.1038/s41541-025-01182-1.
2
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors.
Vaccines (Basel). 2025 Mar 26;13(4):352. doi: 10.3390/vaccines13040352.
3
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.
BMJ Open. 2025 Jan 20;15(1):e084345. doi: 10.1136/bmjopen-2024-084345.
4
SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients.
Clin Transplant Res. 2024 Dec 31;38(4):247-256. doi: 10.4285/ctr.24.0062.
5
Cranial neuropathy following coronavirus disease 2019 vaccination in kidney transplant recipients.
IJU Case Rep. 2024 Oct 2;7(6):423-426. doi: 10.1002/iju5.12761. eCollection 2024 Nov.
6
Binding Mechanism of the Active Form of Molnupiravir to RdRp of SARS-CoV-2 and Designing Potential Analogues: Insights from Molecular Dynamics Simulations.
ACS Omega. 2024 Sep 24;9(40):41583-41598. doi: 10.1021/acsomega.4c05469. eCollection 2024 Oct 8.
7
Risk Factors for Impaired Cellular or Humoral Immunity after Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals.
Vaccines (Basel). 2024 Jul 8;12(7):752. doi: 10.3390/vaccines12070752.
8
Inter- and intra-individual differences regarding SARS-CoV-2 and influenza vaccination in pediatric kidney transplant recipients: An observational study.
Medicine (Baltimore). 2024 Jul 5;103(27):e38809. doi: 10.1097/MD.0000000000038809.
9
Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8 T cell repertoire response to influenza vaccination.
Front Immunol. 2024 May 30;15:1306490. doi: 10.3389/fimmu.2024.1306490. eCollection 2024.
10
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE.
Infect Dis Ther. 2024 Jul;13(7):1419-1438. doi: 10.1007/s40121-024-00987-2. Epub 2024 May 27.
Zotero 插件